Avadel Pharmaceuticals PLC
AVDL11.060USD
-0.020-0.18%
시장 운영 시간 （ET）시세는 15분 지연됩니다
1.07B시가총액
손실P/E TTM
자세한 내용은 Avadel Pharmaceuticals PLC 회사
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.
회사 정보
종목 코드 AVDL
회사 이름Avadel Pharmaceuticals PLC
상장일Jan 16, 1952
CEOMr. Gregory J. (Greg) Divis, Jr.
직원 수188
유형Ordinary Share
회계 연도 종료Jan 16
주소Block 10-1 Blanchardstown Corporate Park
도시DUBLIN
증권 거래소NASDAQ Global Market Consolidated
국가Ireland
우편 번호15
전화35319015201
웹사이트https://www.avadel.com/
종목 코드 AVDL
상장일Jan 16, 1952
CEOMr. Gregory J. (Greg) Divis, Jr.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Eric J. Ende, M.D.
Dr. Eric J. Ende, M.D.
Independent Director
Independent Director
219.90K
+5.27%
Mr. Peter J. Thornton
Mr. Peter J. Thornton
Independent Director
Independent Director
115.06K
+10.57%
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Independent Director
Independent Director
89.03K
+14.10%
Mr. Thomas S. Mchugh
Mr. Thomas S. Mchugh
Chief Financial Officer
Chief Financial Officer
87.80K
-12.55%
Ms. Linda S. Palczuk
Ms. Linda S. Palczuk
Independent Director
Independent Director
78.90K
+16.20%
Ms. Susan Rodriguez
Ms. Susan Rodriguez
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jerad Seurer
Mr. Jerad Seurer
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Mr. Gregory J. (Greg) Divis, Jr.
Mr. Gregory J. (Greg) Divis, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Naseem Amin, M.D.
Dr. Naseem Amin, M.D.
Independent Director
Independent Director
--
--
Ms. Courtney Turiano
Ms. Courtney Turiano
Investor Relations
Investor Relations
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Eric J. Ende, M.D.
Dr. Eric J. Ende, M.D.
Independent Director
Independent Director
219.90K
+5.27%
Mr. Peter J. Thornton
Mr. Peter J. Thornton
Independent Director
Independent Director
115.06K
+10.57%
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Independent Director
Independent Director
89.03K
+14.10%
Mr. Thomas S. Mchugh
Mr. Thomas S. Mchugh
Chief Financial Officer
Chief Financial Officer
87.80K
-12.55%
Ms. Linda S. Palczuk
Ms. Linda S. Palczuk
Independent Director
Independent Director
78.90K
+16.20%
Ms. Susan Rodriguez
Ms. Susan Rodriguez
Chief Operating Officer
Chief Operating Officer
--
--
수익 분석
통화: USD마지막 업데이트: Mon, Mar 3
통화: USD마지막 업데이트: Mon, Mar 3
FY2020
FY2019
사업별USD
이름
수익
비율
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
지역별USD
이름
수익
비율
United States
22.33M
100.00%
Ireland
0.00
0.00%
사업별
지역별
사업별USD
이름
수익
비율
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Janus Henderson Investors
14.03%
Tontine Asset Management, LLC
6.32%
Brandes Investment Partners, L.P.
5.85%
The Vanguard Group, Inc.
5.74%
Two Seas Capital LP
5.10%
Other
62.95%
주주
주주
비율
Janus Henderson Investors
14.03%
Tontine Asset Management, LLC
6.32%
Brandes Investment Partners, L.P.
5.85%
The Vanguard Group, Inc.
5.74%
Two Seas Capital LP
5.10%
Other
62.95%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
28.13%
Investment Advisor
26.80%
Hedge Fund
20.94%
Individual Investor
4.83%
Venture Capital
3.82%
Research Firm
2.59%
Pension Fund
0.47%
Bank and Trust
0.38%
Insurance Company
0.03%
Other
12.03%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
372
85.19M
87.92%
-22.67M
2025Q1
377
85.31M
88.05%
-24.78M
2024Q4
354
86.56M
89.59%
-16.46M
2024Q3
334
81.87M
84.98%
-15.41M
2024Q2
299
81.11M
84.30%
-2.77M
2024Q1
258
76.98M
80.25%
+5.42M
2023Q4
226
62.92M
70.15%
-3.93M
2023Q3
220
60.11M
69.62%
-5.86M
2023Q2
213
57.67M
66.98%
-1.24M
2023Q1
201
54.14M
84.38%
+9.93M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Janus Henderson Investors
13.59M
14.03%
-487.88K
-3.47%
Mar 31, 2025
Tontine Asset Management, LLC
6.13M
6.32%
-203.28K
-3.21%
Mar 31, 2025
Brandes Investment Partners, L.P.
5.67M
5.85%
+3.49M
+160.78%
Mar 31, 2025
The Vanguard Group, Inc.
3.88M
4.01%
-52.69K
-1.34%
Mar 31, 2025
Two Seas Capital LP
4.95M
5.1%
+650.00K
+15.13%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.69M
4.84%
-55.04K
-1.16%
Mar 31, 2025
Polar Capital LLP
4.36M
4.5%
-58.24K
-1.32%
Mar 31, 2025
Kotler (Kevin)
3.72M
3.84%
-1.01M
-21.37%
Feb 12, 2024
Vivo Capital, LLC
2.68M
2.77%
--
--
Mar 31, 2025
Wealth Effects LLC
2.37M
2.44%
+24.99K
+1.07%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
Invesco Pharmaceuticals ETF
2.64%
iShares Neuroscience and Healthcare ETF
1.92%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
Invesco Nasdaq Biotechnology ETF
0.1%
ProShares Ultra Nasdaq Biotechnology
0.1%
Nuveen ESG Small-Cap ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.07%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.06%
Federated Hermes MDT Small Cap Core ETF
0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.05%
더 보기
Invesco Pharmaceuticals ETF
비율2.64%
iShares Neuroscience and Healthcare ETF
비율1.92%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.11%
Invesco Nasdaq Biotechnology ETF
비율0.1%
ProShares Ultra Nasdaq Biotechnology
비율0.1%
Nuveen ESG Small-Cap ETF
비율0.07%
Fidelity Enhanced Small Cap ETF
비율0.07%
iShares MSCI USA Small-Cap Min Vol Factor ETF
비율0.06%
Federated Hermes MDT Small Cap Core ETF
비율0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
비율0.05%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
